Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
11/1999
11/16/1999US5985597 DNA encoding prostaglandin receptor EP1
11/16/1999US5985589 Dna sequences
11/16/1999US5985588 Phagemid for antibody screening
11/16/1999US5985587 Polypeptide-induced monoclonal receptors to protein ligands
11/16/1999US5985586 Methods for identifying compounds that modulate the activity of human N-methyl-D-aspartate receptors
11/16/1999US5985583 Hybridization; measurement signal transduction
11/16/1999US5985581 Use of presenilin-1 for diagnosis of alzheimers disease
11/16/1999US5985580 Antibodies which specifically bind to the thymokine lymphotactin
11/16/1999US5985578 Autoantibodies and their targets in the diagnosis of peripheral neuropathies
11/16/1999US5985562 Analyzing dna sample
11/16/1999US5985552 Vaccination and methods against diseases resulting from pathogenic responses by specific T cell populations
11/16/1999US5985543 Agglutination mixture of cells and bacteriophages
11/16/1999US5985542 Diagnostic kit
11/16/1999US5985334 Contacting test compound to receptor from rat brain tissue that binds 6-acetyl-4-benzamido-3-hydroxy-2,2-dimethylbenzopyran derivatives
11/16/1999US5985287 Compounds and methods for treatment and diagnosis of mycobacterial infections
11/16/1999US5985286 Adenyl cyclase-hemolysin (ac-hly) protein,
11/16/1999US5985280 Diagnosis and/or therapy of tumours using monoclonal antibodies specific for the human IL-4 receptor
11/16/1999US5985279 Humanized antibody against CD18
11/16/1999US5985278 Anti-αV-integrin monoclonal antibody
11/16/1999US5985277 Useful for diagnosis and treatement of corynebacterium infections and diseases.
11/16/1999US5985276 Destruction of contaminating tumor cells in stem cell transplants using bispecific antibodies
11/16/1999US5985262 Method of treatment with epithelium derived T-cell factor
11/16/1999CA2078118C Cc-1065 analogs
11/16/1999CA2056402C Therapeutic agent
11/16/1999CA2037900C Pokeweed antiviral protein - monoclonal antibody conjugates
11/16/1999CA2005926C Process for immobilising a protein on a solid phase
11/11/1999WO1999057565A2 Methods for diagnosing and evaluating cancer
11/11/1999WO1999057288A1 Endothelin-converting-enzyme like protein
11/11/1999WO1999057286A1 Putative lactamase proteins from mouse and human
11/11/1999WO1999057280A2 Neisseria meningitidis antigens and compositions
11/11/1999WO1999057274A1 Human protease associated proteins
11/11/1999WO1999057270A2 Human receptor molecules
11/11/1999WO1999057268A1 Chimeric receptors
11/11/1999WO1999057266A2 Immunosuppression by blocking t cell co-stimulation signal 2 (b7/cd28 interaction)
11/11/1999WO1999057244A1 Genetically modified cells and methods for expressing recombinant heparanase and methods of purifying same
11/11/1999WO1999057241A2 Myelin basic protein peptides and uses thereof
11/11/1999WO1999057153A1 Heparanase specific molecular probes and their use in research and medical applications
11/11/1999WO1999057152A1 Oral administration of immunoglobulins for treating autoimmune hearing loss
11/11/1999WO1999057151A2 FAP α-SPECIFIC ANTIBODY WITH IMPROVED PRODUCIBILITY
11/11/1999WO1999057150A2 Multivalent antibody constructs
11/11/1999WO1999057149A2 Compounds and methods for modulating nonclassical cadherin-mediated functions
11/11/1999WO1999057144A2 Human transcriptional regulator molecules
11/11/1999WO1999057140A2 Growth-associated protease inhibitor heavy chain precursor
11/11/1999WO1999057134A1 Protein purification by ion exchange chromatography
11/11/1999WO1999057131A1 Method of treating bladder and lower urinary tract syndromes
11/11/1999WO1999056783A1 Hydrogel for the therapeutic treatment of aneurysms
11/11/1999WO1999056778A1 The cytokine family member, 2-19
11/11/1999WO1999056777A1 REVERSAL OF PROINFLAMMATORY RESPONSE BY LIGATING THE MACROPHAGE FcηRI RECEPTOR
11/11/1999WO1999056774A1 Viral chimeras comprised of caev and hiv-1 genetic elements
11/11/1999WO1999056768A1 Methods for treating diabetes by inhibiting gdf-8
11/11/1999WO1999049316A3 Peripheral-type benzodiazepine receptor: a tool for detection, diagnosis, prognosis, and treatment of cancer
11/11/1999WO1999047677A3 Polypeptides homologous to vegf and bmp1
11/11/1999WO1999045031A9 Cd147 binding molecules as therapeutics
11/11/1999WO1999042821A3 Treating cancer
11/11/1999WO1999042574B1 Sequences of an ih ionic channel and the use thereof
11/11/1999WO1999040214A3 Nucleic acid delivery vehicles
11/11/1999WO1999029863A9 Human interferon-epsilon: a type i interferon
11/11/1999WO1999027105A3 Chlamydia pneumoniae genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection
11/11/1999DE19819846A1 Multivalente Antikörper-Konstrukte Multivalent antibody constructs
11/11/1999CA2753381A1 Protein purification by ion exchange chromatography
11/11/1999CA2650642A1 Neisseria meningitidis antigens and compositions
11/11/1999CA2331738A1 Oral administration of immunoglobulins for treating autoimmune hearing loss
11/11/1999CA2331607A1 Reversal of proinflammatory response by ligating the macrophage fc.gamma.ri receptor
11/11/1999CA2330838A1 Neisseria meningitidis antigens and compositions
11/11/1999CA2329142A1 Genetically modified cells and methods for expressing recombinant heparanase and methods of purifying same
11/11/1999CA2328505A1 Chimeric receptors
11/11/1999CA2328132A1 Growth-associated protease inhibitor heavy chain precursor
11/11/1999CA2328112A1 Methods for diagnosing and evaluating cancer
11/11/1999CA2327543A1 Method of treating bladder and lower urinary tract syndromes
11/11/1999CA2327530A1 Compounds and methods for modulating nonclassical cadherin-mediated functions
11/11/1999CA2327355A1 Human receptor molecules
11/11/1999CA2327263A1 Human protease associated proteins
11/11/1999CA2327259A1 Human transcriptional regulator molecules
11/11/1999CA2326671A1 Immunosuppression by blocking t cell co-stimulation signal 2 (b7/cd28 interaction)
11/11/1999CA2295323A1 Heparanase specific molecular probes and their use in research and medical applications
11/11/1999CA2248963A1 Novel compounds
11/10/1999EP0955366A1 Antigenic protein originating in malassezia
11/10/1999EP0955361A1 Monoclonal antibodies to tumor-associated antigens, methods for their production, and their use
11/10/1999EP0955311A2 Peptide vaccine for canine allergy
11/10/1999EP0955061A1 Oral product for the prevention and therapy of porcine gastroenteric infections
11/10/1999EP0955060A1 Remedies for acute pulmonary injuries due to indirect causes containing anti-il-8 antibody as the active ingredient
11/10/1999EP0954978A1 New products comprising inactivated yeasts or moulds provided with active antibodies
11/10/1999EP0954602A1 Hereditary hemochromatosis gene
11/10/1999EP0954594A2 Immortalized hematopoietic cell lines, cell system thereof with stromal cells, in vitro, ex vivo and in vivo uses, and in vitro generation of dendritic cells and macrophages
11/10/1999EP0954585A2 Human telomerase catalytic subunit
11/10/1999EP0954580A1 Human sdf-5 protein and compositions
11/10/1999EP0954535A1 Antibodies that bind to the nidogen-binding domain of laminin, their production and use
11/10/1999EP0954534A1 Pasteurization of immunoglobulin solutions
11/10/1999EP0954533A1 Von willebrand factor derivative and method for isolating proteins
11/10/1999EP0954532A1 Novel human apoptosis regulator
11/10/1999EP0954531A1 aPL IMMUNOREACTIVE PEPTIDES, CONJUGATES THEREOF AND METHODS OF TREATMENT FOR aPL ANTIBODY-MEDIATED PATHOLOGIES
11/10/1999EP0954529A1 Porphyromonas gingivalis antigens for the diagnosis and treatment of periodontitis
11/10/1999EP0954525A1 Novel compounds
11/10/1999EP0954335A1 Methods of delaying development of cea-associated tumors using anti-idiotype antibody 3h1
11/10/1999EP0954334A1 Use of macrophage migration inhibitory factor antagonists for anti-cancer therapy
11/10/1999EP0954333A2 Soluble lymphotoxin-beta receptors, anti-lymphotoxin receptor antibodies, and anti-lymphotoxin ligand antibodies as therapeutic agents for the treatment of immunological diseases
11/10/1999EP0954331A1 Novel compounds
11/10/1999EP0954330A1 Intestinal trefoil proteins
11/10/1999EP0954326A1 A process for viral inactivation of lyophilized blood proteins
11/10/1999EP0724588B1 Drug binding protein
1 ... 1202 1203 1204 1205 1206 1207 1208 1209 1210 1211 1212 1213 1214 1215 1216 1217 1218 1219 1220 1221 1222 ... 1494